Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-33.84	67.29	101.71
Graham Fair Price	49.22	55.95	37.49
PEG	19.71	-0.12	0.10
Price/Book	8.91	1.23	1.13
Price/Cash Flow	133.61	94.86	40.60
Prices/Earnings	53.92	-16.17	-35.10
Price/Sales	10.19	4.51	4.09
Price/FCF	133.61	94.86	40.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	20.66	0.32	0.27
Operating Margin	-79.65	< 0.005	-0.03
ROA	-135.03	< 0.005	< 0.005
ROE	< 0.005	-0.02	-136.38
ROIC	< 0.005	< 0.005	-54.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.04	-75.98
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.84	1.20	-35.05
EPS QOQ	-3.37	-1.30	61.51
FCF QOQ	4.59	-0.55	-88.11
Revenue QOQ	0.06	-0.04	-40.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	148.41	162.98	9.82
Days Sales Outstanding (DSO)	25.15	26.87	6.86
Inventory Turnover	0.61	0.55	-8.94
Debt/Capitalization	0.44	0.45	2.76
Quick Ratio	0.87	0.93	6.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	87.96	85.37	-2.95
Cash	10.55	10.43	-1.17
Capex	-1.32	-0.78	41.18
Free Cash Flow	2.46	1.11	-54.75
Revenue	24.36	23.37	-4.07
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.53	2.61	3.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	38.24	24.22	-36.67
Naive Interpretation	Member

06 - Financial Health · Bad

Rating